BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mao X, Liu Z, Shi O, Yu K, Jiang Y, Jin L, Zhang T, Chen X. Non-invasive fibrosis markers are associated with mortality risk in both general populations and non-alcoholic fatty liver disease patients. Hepatol Res 2021;51:90-101. [PMID: 32946623 DOI: 10.1111/hepr.13570] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Liu F, Song T, Li Z, Xia P, Tang X, Xu M, Shen Y, Ma J, Liu X, Yu P. Liver Fibrosis Scores and Clinical Outcomes in Patients With COVID-19. Front Med 2022;9:829423. [DOI: 10.3389/fmed.2022.829423] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Shi YY, Zheng R, Cai JJ, Fang ZD, Chen WJ, Pan JY, Qian SZ. Association of FIB-4 index and clinical outcomes in critically ill patients with acute kidney injury: a cohort study. BMC Gastroenterol 2021;21:483. [PMID: 34930141 DOI: 10.1186/s12876-021-02071-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang H, Wu J, Yang X, Liu J, Tao W, Hao Z, Wu B, Liu M, Zhang S, Wang D. Liver fibrosis indices associated with substantial hematoma expansion in Chinese patients with primary intracerebral hemorrhage. BMC Neurol 2021;21:478. [PMID: 34879856 DOI: 10.1186/s12883-021-02494-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]